We are live on ! Find out more
NPA

Nichols & Pratt Advisers Portfolio holdings

AUM $1.55B
1-Year Est. Return 14.55%
This Fund
S&P 500
This Quarter Est. Return
+3.06%
1 Year Est. Return
+14.55%
3 Year Est. Return
+54.54%
5 Year Est. Return
+81.09%
10 Year Est. Return
+238.91%
AUM
$1.12B
AUM Growth
+$18.6M
Cap. Flow
-$9.58M
Cap. Flow %
-0.86%
Top 10 Hldgs %
43.01%
Holding
112
New
3
Increased
29
Reduced
41
Closed
3

Top Buys

Rank Stock Value
1
ACN icon
Accenture
ACN
+$1.12M
2
KMI icon
Kinder Morgan
KMI
+$923K
3
VZ icon
Verizon
VZ
+$817K
4
TJX icon
TJX Companies
TJX
+$766K
5
SO icon
Southern Company
SO
+$749K

Top Sells

Rank Stock Value
1
MON
Monsanto Co
MON
+$7.67M
2
PX
Praxair Inc
PX
+$2.21M
3
EMR icon
Emerson Electric
EMR
+$1.02M
4
SYY icon
Sysco
SYY
+$881K
5
GE icon
GE Aerospace
GE
+$686K

Sector Composition

Rank Sector Weight
1 Healthcare 21.52%
2 Technology 20.37%
3 Consumer Staples 17.42%
4 Industrials 13.66%
5 Financials 7.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VZ icon
26
Verizon
VZ
$195B
$16.5M 1.47%
327,429
+16,876
+5% +$817K
SLB icon
27
SLB Ltd
SLB
$73.6B
$16.4M 1.46%
244,051
-1,173
-0.5% -$80.5K
SYY icon
28
Sysco
SYY
$40.8B
$16.2M 1.45%
236,871
-13,785
-5% -$881K
KMI icon
29
Kinder Morgan
KMI
$71.7B
$15.1M 1.35%
853,130
+56,445
+7% +$923K
EXPD icon
30
Expeditors International
EXPD
$22B
$14.8M 1.32%
202,476
+2,500
+1% +$175K
CVS icon
31
CVS Health
CVS
$133B
$14.2M 1.27%
221,331
+2,921
+1% +$192K
UL icon
32
Unilever
UL
$137B
$14M 1.25%
224,449
-107
-0% -$6.65K
WBA
33
DELISTED
Walgreens Boots Alliance
WBA
$11.8M 1.05%
196,174
+4,485
+2% +$289K
SO icon
34
Southern Company
SO
$109B
$11.4M 1.02%
246,641
+16,734
+7% +$749K
SYK icon
35
Stryker
SYK
$125B
$11.2M 1%
66,470
-15
-0% -$2.52K
MMM icon
36
3M
MMM
$90.9B
$10.9M 0.98%
66,389
-179
-0.3% -$30.5K
GILD icon
37
Gilead Sciences
GILD
$162B
$10.8M 0.96%
152,067
-2,690
-2% -$190K
QCOM icon
38
Qualcomm
QCOM
$155B
$10.4M 0.93%
185,715
+421
+0.2% +$23.5K
NVO
39
Novo Nordisk
NVO
$208B
$10.3M 0.92%
448,010
+15,200
+4% +$361K
MDT icon
40
Medtronic
MDT
$109B
$9.12M 0.82%
106,561
+906
+0.9% +$75.7K
INTU icon
41
Intuit
INTU
$86.5B
$9.11M 0.82%
44,589
-780
-2% -$150K
AMZN icon
42
Amazon
AMZN
$2.92T
$7.06M 0.63%
83,040
+8,880
+12% +$705K
SBUX icon
43
Starbucks
SBUX
$120B
$6.08M 0.54%
124,452
+135
+0.1% +$7.66K
ABT icon
44
Abbott
ABT
$183B
$3.93M 0.35%
64,486
+350
+0.5% +$21.2K
T icon
45
AT&T
T
$159B
$3.19M 0.29%
131,459
-3,707
-3% -$93K
PFE icon
46
Pfizer
PFE
$143B
$3.16M 0.28%
91,892
JPM icon
47
JPMorgan Chase
JPM
$935B
$2.7M 0.24%
25,937
-100
-0.4% -$11K
MKC icon
48
McCormick & Company Non-Voting
MKC
$13.7B
$2.56M 0.23%
44,140
-400
-0.9% -$21K
IWM icon
49
iShares Russell 2000 ETF
IWM
$79.8B
$2.19M 0.2%
13,395
+426
+3% +$68.1K
ABBV icon
50
AbbVie
ABBV
$443B
$1.86M 0.17%
20,080
-250
-1% -$24.4K

Similar funds

Nichols & Pratt Advisers's Q2 2018 Portfolio in Review

As of Q2 2018, Nichols & Pratt Advisers held 112 positions worth $1.12B, up 1.7% from $1.1B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Nichols & Pratt Advisers's Q2 2018 filing shows 3 new, 29 increased, 41 reduced and 3 closed positions. Its largest new stake was Avery Dennison: 2,000 shares worth $204K. The largest sale was Monsanto Co, an estimated $7.67M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Technology and Consumer Staples.

  • Nichols & Pratt Advisers's largest Q2 2018 buy was Avery Dennison: 2,000 shares worth $204K.
  • Nichols & Pratt Advisers added most to Accenture in Q2 2018, an estimated $1.12M increase.
  • Nichols & Pratt Advisers's biggest Q2 2018 reduction was Praxair Inc, cutting an estimated $2.21M.
  • Nichols & Pratt Advisers fully exited Monsanto Co in Q2 2018, selling an estimated $7.67M.
  • Nichols & Pratt Advisers's ten largest holdings make up 43% of its $1.12B portfolio in Q2 2018.
  • Nichols & Pratt Advisers opened 3 new positions and closed 3 in Q2 2018.
  • Nichols & Pratt Advisers's portfolio value rose 1.7% quarter-over-quarter to $1.12B.

Based on Nichols & Pratt Advisers's 13F filing for Q2 2018, filed 27 Jul 2018.